Pfizer | 8-K: Pfizer Reports First-Quarter 2024 Results
May 1 08:14 ET
Pfizer | 8-K: Poll Results of Pfizer Meeting
Apr 29 10:22 ET
Pfizer | DEFA14A: Others
Apr 11 11:04 ET
Pfizer | DEFA14A: Others
Apr 11 11:00 ET
Pfizer | DEFA14A: Others
Apr 11 11:00 ET
Pfizer | DEFA14A: Others
Apr 9 10:34 ET
Pfizer | DEFA14A: Others
Mar 28 16:26 ET
Pfizer | DEFA14A: Others
Mar 28 16:17 ET
Pfizer | DEFA14A: Others
Mar 14 09:09 ET
Pfizer | DEF 14A: Definitive information statements
Mar 14 09:09 ET
Pfizer | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 23 16:42 ET
Pfizer | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Feb 23 16:41 ET
Pfizer | 8-K: Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
Jan 30 08:07 ET
Pfizer | 8-K: Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
Jan 10 00:00 ET
Pfizer | 8-K/A: Pfizer Completes Acquisition of Seagen
Dec 14, 2023 17:04 ET
Pfizer | 8-K: Pfizer Completes Acquisition of Seagen
Dec 14, 2023 07:51 ET
Pfizer | 8-K: Pfizer Provides Full-Year 2024 Guidance
Dec 13, 2023 07:44 ET
Pfizer | 8-K: Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
Dec 12, 2023 16:35 ET
Pfizer | 8-K: Pfizer Reports Third-Quarter 2023 Results
Oct 31, 2023 08:04 ET
Pfizer | 8-K: Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance
Oct 13, 2023 17:30 ET
No Data
No Data